Rotator Cuff Repair & Reconstruction Market Size, Share and Trends Analysis - Global - 2023-2029 - MedCore - Includes: Grafts (Allografts, Xenograft, Synthetic), and 1 more

Rotator Cuff Repair & Reconstruction Market Size, Share and Trends Analysis - Global - 2023-2029 - MedCore - Includes: Grafts (Allografts, Xenograft, Synthetic), and 1 more

Overall, the global rotator cuff repair and reconstruction market was valued at over $1.4 billion in 2022. This is expected to increase over the forecast period at a CAGR of 5.4% to reach approximately $2.1 billion.
The full report suite on the global market for rotator cuff repair and reconstruction includes subsegments for grafts (i.e., allograft, xenograft and synthetic) and suture anchors (i.e. biocomposite, polyether ether ketone (PEEK), PEEK carbon fiber (CF) metal, all-suture, polylactic acid (PLA)).

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends
Forecasts Until 2029, and Historical Data to 2019
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
Procedure Volumes
Company Profiles, Product Portfolios and SWOT for Top Competitors
COVID-19 Impact Analysis

PROCEDURE NUMBERS

More than 50% of all rotator cuff repair procedures in 2022 were performed using double row techniques, which reflect surgeon preferences based on the type of tear. Nevertheless, over the forecast period, single row procedures are expected to gain popularity as they have been found to be a viable and effective option for treating rotator cuff tears. In fact, clinical evidence suggests that there is no substantial difference in outcomes between the two techniques. Consequently, both single and double row procedures are anticipated to grow at a moderate single-digit CAGR over the forecast period.

GLOBAL ROTATOR CUFF REPAIR & RECONSTRUCTION MARKET TRENDS

The market growth for treatments of rotator cuff tears is constrained by the fact that some tears can be effectively managed without surgery. Usually, physical or occupational therapy is the initial treatment option, and medication may also be prescribed. However, the efficacy of non-surgical therapy is heavily reliant on the state of the rotator cuff and may offer only temporary relief before surgical intervention is required.

GLOBAL ROTATOR CUFF REPAIR & RECONSTRUCTION MARKET SHARE INSIGHTS

The global rotator cuff repair and reconstruction market is primarily dominated by three major competitors, namely Arthrex, DePuy Synthes, and Smith & Nephew.
In 2022, Arthrex was the market leader in the rotator cuff repair market, capturing almost half of the market share. Arthrex has been able to maintain its leading position in the rotator cuff repair market by extensively promoting its range of biocomposite suture anchors, which include FASTak®, KnotlessSutureTak®, LabralSwiveLock®, and PushLock™.

GLOBAL ROTATOR CUFF REPAIR & RECONSTRUCTION MARKET SEGMENTATION SUMMARY

Graft Market - MedCore – Includes:
Allograft, xenograft, and synthetic.
Suture Anchor Market - MedCore – Includes:
Biocomposite, polyether ether ketone (PEEK), PEEK carbon fiber (CF) metal, all-suture, polylactic acid (PLA).

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.